pbm glp-1 news Medicare UPDATE + MASSIVE Compounding Fmr. FDA Commissioner weighs in
Description
In a study led by researchers atMass General Brigham, pregnant individuals who stopped taking popular weight loss GLP-1 medications before or early in their pregnancy tended to gain
More than appetite support
Tirzepatide is a new drug targeting glucagon-like peptide 1(GLP1) and gastric inhibitory polypeptide (GIP) receptors
These medications help regulate blood sugar and promote weight loss by reducing appetite and slowing gastric emptying
Click to learn more & contact us today to set up a weight loss consultation!
